BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29934769)

  • 1. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis.
    Capobianco G; Azzena A; Saderi L; Dessole F; Dessole S; Sotgiu G
    Int Urogynecol J; 2018 Sep; 29(9):1239-1247. PubMed ID: 29934769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation.
    Futyma K; Miotła P; Gałczyński K; Baranowski W; Doniec J; Wodzisławska A; Jóźwik M; Oniszczuk M; Rechberger T
    Biomed Res Int; 2015; 2015():851823. PubMed ID: 26106616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Para-Urethral Injections with Urolastic® for Treatment of Female Stress Urinary Incontinence: Subjective Improvement and Safety.
    de Vries AM; van Breda HMK; Fernandes JG; Venema PL; Heesakkers JPFA
    Urol Int; 2017; 99(1):91-97. PubMed ID: 28152525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonabsorbable urethral bulking agent - clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up.
    Futyma K; Nowakowski Ł; Gałczyński K; Miotła P; Rechberger T
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():68-72. PubMed ID: 27825030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bulking for stress urinary incontinence in men: A systematic review.
    Toia B; Gresty H; Pakzad M; Hamid R; Ockrim J; Greenwell T
    Neurourol Urodyn; 2019 Sep; 38(7):1804-1811. PubMed ID: 31321804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of an innovative bulking agent in patients with stress urinary incontinence who are not optimal candidates for mid-urethral sling surgery.
    Kowalik CR; Casteleijn FM; van Eijndhoven HWF; Zwolsman SE; Roovers JWR
    Neurourol Urodyn; 2018 Jan; 37(1):339-345. PubMed ID: 28452427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross-sectional study.
    Casteleijn FM; Kowalik CR; Berends C; Blaganje M; Lasić Pecev M; van der Linden E; Zwolsman SE; Roovers JWR; Minnee P
    Neurourol Urodyn; 2020 Aug; 39(6):1753-1763. PubMed ID: 32526063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review.
    Siddiqui ZA; Abboudi H; Crawford R; Shah S
    Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review.
    Hoe V; Haller B; Yao HH; O'Connell HE
    Neurourol Urodyn; 2021 Aug; 40(6):1349-1388. PubMed ID: 34015151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urethral bulking agents for female stress urinary incontinence.
    Hussain SM; Bray R
    Neurourol Urodyn; 2019 Mar; 38(3):887-892. PubMed ID: 30801773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urolastic for the treatment of women with stress urinary incontinence: 24-month follow-up.
    Zajda J; Farag F
    Cent European J Urol; 2015; 68(3):334-8. PubMed ID: 26568877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urolastic-a new bulking agent for the treatment of women with stress urinary incontinence: outcome of 12 months follow up.
    Zajda J; Farag F
    Adv Urol; 2013; 2013():724082. PubMed ID: 24454351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of polydimethylsiloxane injection (Macroplastique
    Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F;
    BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and effectiveness of bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis.
    Capobianco G; Saderi L; Dessole F; Petrillo M; Dessole M; Piana A; Cherchi PL; Dessole S; Sotgiu G
    Maturitas; 2020 Mar; 133():13-31. PubMed ID: 32005420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis.
    Leone Roberti Maggiore U; Bogani G; Meschia M; Sorice P; Braga A; Salvatore S; Ghezzi F; Serati M
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():48-54. PubMed ID: 25855326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
    Ayeleke RO; Hay-Smith EJ; Omar MI
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010551. PubMed ID: 24259154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence.
    Ghoniem GM; Miller CJ
    Int Urogynecol J; 2013 Jan; 24(1):27-36. PubMed ID: 22699885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Urethral Bulking for Stress Urinary Incontinence in Women.
    Zheng Y; Rovner E
    Curr Urol Rep; 2022 Oct; 23(10):203-209. PubMed ID: 35781870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periurethral injection therapy for urinary incontinence in women.
    Pickard R; Reaper J; Wyness L; Cody DJ; McClinton S; N'Dow J
    Cochrane Database Syst Rev; 2003; (2):CD003881. PubMed ID: 12804494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periurethral injection therapy for urinary incontinence in women.
    Keegan PE; Atiemo K; Cody J; McClinton S; Pickard R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD003881. PubMed ID: 17636740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.